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Abstract
Background: Inappropriate medication use is a major healthcare issue for the elderly population.
This study explored the prevalence of potentially inappropriate prescriptions (PIPs) in long-term
care in metropolitan Quebec.
Methods: A cross sectional chart review of 2,633 long-term care older patients of the Quebec
City area was performed. An explicit criteria list for PIPs was developed based on the literature
and validated by a modified Delphi method. Medication orders were reviewed to describe
prescribing patterns and to determine the prevalence of PIPs. A multivariate analysis was
performed to identify predictors of PIPs.
Results: Almost all residents (94.0%) were receiving one or more prescribed medication; on
average patients had 4.8 prescribed medications. A majority (54.7%) of treated patients had a
potentially inappropriate prescription (PIP). Most common PIPs were drug interactions (33.9% of
treated patients), followed by potentially inappropriate duration (23.6%), potentially inappropriate
medication (14.7%) and potentially inappropriate dosage (9.6%). PIPs were most frequent for
medications of the central nervous system (10.8% of prescribed medication). The likelihood of PIP
increased significantly as the number of drugs prescribed increased (odds ratio [OR]: 1.38, 95%
confidence interval [CI]: 1.33 – 1.43) and with the length of stay (OR: 1.78, CI: 1.43 – 2.20). On the
other hand, the risk of receiving a PIP decreased with age.
Conclusion: Potentially inappropriate prescribing is a serious problem in the highly medicated
long-term care population in metropolitan Quebec. Use of explicit criteria lists may help identify
the most critical issues and prioritize interventions to improve quality of care and patient safety.
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Inappropriate medication use is a major health care issue
for the elderly population [1-3]. Older patients are more
at risk for adverse medication outcomes because they
often have complex drug regimens and because of the age-
related changes in drug pharmacokinetics and pharmaco-
dynamics [1]. Potentially inappropriate prescriptions
(PIPs), defined as prescriptions in which risks outweigh
benefits, have been assessed in various settings using lists
of explicit criteria most often based on that developed by
Beers [4]. PIPs have been estimated to affect 4.8% to
45.6% of the elderly population [5-12].
Prevalence estimates of PIPs are likely to vary with the cri-
teria that are applied. Some authors have based their
assessment on the Beers criteria [5-7,9-12]. However, in
all these studies but one [7], criteria applied were a subset
only of Beers criteria as dosage and duration was not eval-
uated. Despite controversy about which explicit criteria
should be used, there is a strong body of evidence show-
ing that suboptimal prescribing is disturbingly common
in older patients.
In Canada, a list of explicit criteria was developed by a
panel of experts in 1997 [13]. The Canadian criteria
required diagnostic information which is not easily acces-
sible in the long-term care setting [6,14]. Using various
methodologies, several studies have investigated the
extent of the problem in Canada. A 1995 study of commu-
nity-dwelling and institutionalized older patients
reported large variations in PIPs among provinces, rang-
ing from 4.8% in the prairies to 12.8% in Quebec [9].
More recently, the prevalence of PIPs in long-term care
patients in Ontario was reported to range between 14.9%
and 20.8% [15-17]. In Quebec, a 1990 retrospective data-
base survey of 63,268 older Medicare patients reported
that 45.6% of non-institutionalized patients received
high-risk prescriptions of questionable appropriateness
[8], while a recent survey of 3,400 elderly patients in the
Quebec general population reported that 6.5% had a
potentially inappropriate prescription (PIP) [18]. A 1995
physician survey reported that 77.1% of nursing home
patients in Quebec had been taking benzodiazepine for
over one year [19].
The long-term care elderly population is particularly vul-
nerable to inappropriate medication use; it is composed
of frail older patients who typically have functional disa-
bilities and acute and chronic medical histories that
require complex medication regimens [20,21]. Assessing
PIPs using the data available in long-term care, in particu-
lar data on dosage and duration of use, may help design-
ing efficient interventions to improve prescribing
practices in one of the frailest populations. The objectives
of this study were (1) to describe prescribing patterns in
elderly patients residing in long-term care facilities in the
Quebec metropolitan area, (2) to assess the prevalence of
PIPs in this long-term care setting using published explicit
criteria [4,13,22] adapted for this study, and (3) to iden-
tify patient-related predictors of PIPs.
Methods
Design and data sources
A cross-sectional chart review of long-term care patients
aged 65 years and over living in the Quebec City area was
performed in the period between April 1995 and Decem-
ber 1996. All long-term care facilities located in the Que-
bec City area were contacted and the majority (29 out of
33) agreed to participate in the study. Within the 29 par-
ticipating facilities, there were a total of 71 long-term care
units. Numbers of beds in these units averaged 41 (10 to
190). Units were visited once during the study period.
Data on drugs currently being prescribed the day of the
visit was collected using medication charts. Demographic
data included age, gender and length of stay. This study
was approved by the ethics committees at Université
Laval, Hôpital Saint-François d'Assise and Hôpital de
l'Enfant-Jésus.
For each medication order, the name, dosage, frequency
of dosing and nature of prescription (scheduled or given
on an as-needed basis) were collected. To capture the full-
est possible extent of potentially inappropriate prescrib-
ing, it was assumed that all medications prescribed on an
as-needed basis were taken. The total daily dose of an as-
needed prescription was calculated by multiplying the
prescribed unit dose with the indicated daily frequency of
administration. Prescriptions for creams, ointments and
drops were not included. Each medication was classified
using the Anatomical Therapeutic Chemical (ATC) classi-
fication system [23]. The maximal prescribed daily dose
was calculated for each medication order.
Classification of potentially inappropriate prescribing
A list of explicit criteria for PIP in older patients was devel-
oped based on a review of the literature
[4,6,10,11,13,14,22]. Criteria referring to medications
unavailable in Canada were excluded. Because diagnostic
information is difficult to obtain in the long-term care set-
ting [6,14], criteria involving clinical information were
also excluded. The list of criteria was elaborated using a
modified Delphi method [24]. A consensus panel of four
local experts was convened including a general practi-
tioner with a geriatric practice (RV), a family physician
(LB), a clinical pharmacist and a pharmacoepidemiologist
(JPG), all involved in practice or research on medication
issues in the elderly population. In the first step, experts
were asked to review and comment independently on the
preliminary list of published criteria. Responses from the
experts were used to revise this list. In the second step, thePage 2 of 9
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reached. A total of 111 explicit criteria were included in
the list to assess the quality of prescribing (Appendix).
Medication charts were reviewed and compared with the
list of explicit criteria. PIPs were categorized as:
• Potentially inappropriate medication;
• Potentially inappropriate duration;
• Potentially inappropriate dosage; and
• Potentially inappropriate drug-drug interaction.
Data analyses
Drug prescribed and PIP data were stratified by age and
gender. Chi-square and Student t tests were used to com-
pare proportions and means, respectively. Association
between age and drug utilization was evaluated by analy-
sis of variance. Factors predicting PIP were identified by
logistic regression analyses. Independent variables were
age, sex, number of prescribed drugs and length of stay.
An initial bivariate analysis allowed calculation of crude
odds ratios, identification of variables individually associ-
ated with the risk of PIP, and determination of the appro-
priate scale for each variable. A multivariate analysis with
a significance threshold of 0.10 for the inclusion of varia-
bles subsequently yielded adjusted odds ratios for the
number of prescribed medications, age and length of stay.
Data were analyzed for collinearity and overdispersion.
Data analyses were performed using SAS version 6.12
(SAS Institute Inc. Cary, NC).
Results
Study population
The study population included 2,633 individuals, aged 65
years and older, residing in long-term care facilities for a
mean duration of 8.5 years. Mean age was 82 ± 8 years and
the majority of individuals were women (74.2%). Women
were older than men (84 ± 8 years versus 79 ± 8 years, p =
.0001).
Drug utilization
Most residents (94%, n = 2,481) had one or more pre-
scribed medications and 48% (n = 1,266) of the total pop-
ulation had five or more medications. Residents had on
average 4.8 prescribed medications. Proportions of
patients by number of prescribed medications were simi-
lar for men and women, but varied according to age. The
oldest patients, aged 85 years and more, received signifi-
cantly less medications than their youngest counterparts
aged between 65 and 74 years; 43.8% of patients aged
over 85 years received five medications or more, com-
pared to 59.4% of those aged 65 to 74 years. Of the
12,707 medications prescribed, 86% were scheduled
administrations and 82% were prescribed for more than
three months.
A majority of patients (85.5%, n = 2,251 patients) had a
prescription for medications of the central nervous system
(CNS). Cardiovascular medications (46.4%, n = 1,221
patients) and medications of the alimentary tract and
metabolism (29.3%, n = 772 patients) were the following
most frequently prescribed anatomical groups of medica-
tions. Most commonly prescribed therapeutic classes
included analgesics (48.0%), anxiolytics (41.4%), antip-
sychotics (35.0%) and loop (high-ceiling) diuretics
(18.6%) (Table 1). There were differences in therapeutic
classes prescribed to men and women. Acetaminophen
(36.7% of patients), haloperidol (20.5% of patients) and
lorazepam (20.2% of patients) were the three most fre-
quently prescribed drugs (Table 2).
Potentially inappropriate prescribing
Overall, 51.5% of the population under study had one or
more PIPs. Of the 2,481 patients with at least one pre-
scribed drug, more than half (54.7%) had one or more
PIPs; 29.5% had one PIP, 12.5% had two PIPs, 7.5% had
three PIPs and 5.3% had four or more PIPs.
A total of 12,707 drugs were prescribed of which 1807
were given on an as-needed basis. The proportion of PIPs
among scheduled and as-needed prescriptions were 9.2%
and 11.5%, respectively. If we exclude as-needed prescrip-
tions, 46.4% of all residents had one or more PIPs.
The most common type of PIP was drug-drug interaction,
affecting 33.9% of patients treated with drugs, followed
by potentially inappropriate duration (23.6%), poten-
tially inappropriate medication (14.7%), and potentially
inappropriate dosage (9.6%) (Figure 1). The proportion
of patients receiving any type of PIP decreased with age,
from 66.7% for patients aged 65 to 74 years to 56.4% for
those aged 75 to 84 years and 47.7% for patients aged 85
years and more. PIPs were the most frequent for CNS
medications, representing 9.3% of prescribed
medications.
The most common PIP was a potentially inappropriate
duration for intermediate and short-acting benzodi-
azepines for more than one month (22.9%); more than
half of those PIPs were for the anxiolytic oxazepam (Table
3). A substantial number of patients treated with pharma-
cotherapy were receiving repeat (dual) prescriptions of
antipsychotics (16.5%) or benzodiazepines (14.9%).
Almost 6% of patients treated with pharmacotherapy
were prescribed potentially inappropriate long-acting
benzodiazepines and 5.2% were receiving haloperidol atPage 3 of 9
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PIP among cardiovascular drugs was repeat prescription
of calcium channel blockers, affecting 3.1% of treated
patients.
Predictors
Multivariate analysis indicated that patients with a length
of stay 10 years or over were 1.78 times at greater risk of
being prescribed a PIP than those with less than 10 years
of stay (adjusted odds ratio [OR]: 1.78, 95% confidence
interval [CI]: 1.43–2.20) (Table 4). The risk of PIP also
increased significantly as the number of drugs prescribed
increased (OR: 1.36, CI: 1.32–1.41) whereas it decreased
with age. Gender was not a significant predictor of PIP. No
problems of collinearity or overdispersion were observed
in the multivariate model.
Discussion
The long-term care elderly population evaluated in this
study was highly medicated and a majority of patients
receiving medication had a PIP. These results indicate that
potentially inappropriate prescribing was significant at
the time of the study in institutionalized older patients in
the Quebec metropolitan area.
A total of 94% of residents in this long-term care popula-
tion were prescribed at least one drug, compared to 60%
in community-dwelling elderly patients in Quebec [25].
Table 1: Proportion (in %) of elderly patients on medication by therapeutic class and sex*
Proportion of patients (%)
Therapeutic class All (n = 2,633) Men (n = 680) Women (n = 1,953) p value
Analgesics & antipyretic 48.0 44.6 49.2 0.037
Anxyolitics 41.4 41.4 41.4 0.983
Antipsychotics 35.0 39.5 33.5 0.004
Loop (high ceiling) diuretics 18.6 16.2 19.4 0.062
Antiepileptics 14.9 21.6 12.6 <0.001
Thyroid preparations 14.6 8.4 16.8 <0.001
Vasodilators 14.6 11.0 15.8 0.002
Antidepressants 13.7 11.0 14.7 0.017
Cardiac glycosides 12.4 11.6 12.7 0.462
Drugs for peptic ulcer 11.0 11.3 10.9 0.765
Hypnotics & sedatives 10.9 9.8 11.3 0.293
Anticholinergics 10.9 11.2 10.8 0.788
Selective calcium channel blockers 10.6 7.2 11.7 0.001
Angiotensin converting enzyme inhibitors 10.0 10.0 10.0 0.991
* Only therapeutic classes prescribed to 10% or more of the elderly are displayed
Table 2: Most frequently prescribed medications among the elderly in long-term care
Proportion of patients (%)
ATC code Medication Men (n = 680) Women (n = 1,953) All (n = 2,633)
N02BE01 Acetaminophen 30.5 38.9 36.7
N05AD01 Haloperidol 21.9 20.1 20.5
N05BA06 Lorazepam 20.2 20.2 20.2
C03CA01 Furosemide 16.2 19.2 18.6
N02BA01 Acetyl salicylic acid 19.1 16.7 17.3
N05BA04 Oxazepam 16.3 17.1 16.9
H03AA01 Levothyroxin sodium 8.4 16.8 14.6
C01DA02 Nitroglycerin 10.0 14.6 13.4
C01AA05 Digoxin 11.6 12.7 12.4
ATC: Anatomical Therapeutic ClassificationPage 4 of 9
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than in community-dwelling individuals in Quebec (2.9)
[25], but lower than in American long-term care (7.2) [7].
The total prevalence of PIPs among the population under
study was high (51.5%). Estimates of PIP prevalence in
the literature vary between 4.8% [6] and 45.6% [8] for
both institutionalized and community-dwelling older
patients. Caution must be used when comparing these
results, as the delivery of care may vary from one setting
and one region to another [9]. The current lack of consen-
sus when defining lists of criteria and variations with
respect to methodologies also contribute to the observed
differences [26]. For example, Zhan and colleagues [5]
estimated the proportion of potentially inappropriate
medication use in the community-dwelling elderly in the
United States. Applying criteria on the indication for the
use of 33 drugs, they observed a prevalence of 21.3% for
1996. In our study, PIPs were identified using an explicit
criteria list that was primarily based on Beers and McLeod
criteria [4,13,22] and that was updated and validated by
local experts to apply to the long-term care context in
Quebec. As we had access to dosage and duration infor-
mation, we were able to apply a broader set of criteria
which can explain the higher prevalence of PIPs we have
observed. Explicit criteria lists, such as those developed by
Beers and McLeod, define inappropriate prescription
according to the drug overall risk-benefit profile for eld-
erly patients. These lists were previously used in studies
examining inappropriate prescribing in elderly popula-
tions [3,5,6,11,15,27-30] and undergo a continuous proc-
ess of revision and updating to reflect the most current
clinical information on the risks and benefits of medica-
tions [31].
A large number of patients were receiving CNS medica-
tion (85%) and the most common PIPs were related to
that category of drugs. Thirty-five percent of patients were
prescribed antipsychotics and 22.9% had benzodiazepine
for potentially inappropriate duration, defined as more
than a month [32]. A number of studies have reported the
inappropriate use of CNS drugs [5,8,33,34], particularly
benzodiazepines [18,19]. Many factors may contribute to
the continued use of inappropriate CNS medications,
including prescriber attitudes, patient demands and the
design of the health care system [34]. A survey of physi-
cians in Quebec reported that the psychological distress of
aging patients and the quasi-absence of reported side-
effects justified the long-term use of psychotropic medica-
tion, which was seen as the most effective way of helping
the patient [35]. Moreover, side effects of psychoactive
medication are often believed to be a consequence of the
Potentially inappropriate prescribing including inappropriate medication, dosage, duration and potential drug-drug interaction amo g three age-groups of long-term care elderly (N = 2,481)Figure 1
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inappropriate psychoactive medications can produce a
physical dependence [34]. Psychoactive pharmacotherapy
increases risk of hip fractures and is advocated for use with
caution to prevent falls in elderly populations [36,37].
Anticonvulsants, antidepressants and short- and long-act-
ing benzodiazepines were reported to increase risk of falls
in older women [38].
The length of stay was positively associated with PIPs,
while the prevalence of PIPs decreased with age. Although
the association between length of stay and the likelihood
of receiving a PIP in nursing homes was studied in the past
[6], to our knowledge, this is the first time it is being
shown to be a predictor of PIPs. On the other hand, the
risk of receiving a PIP was previously reported to decrease
with age in nursing home patients over 65 years [7,12].
Data on clinical status was not considered in these studies
and it can be hypothesized that either the oldest residents
were less ill or that physicians were more cautious when
prescribing to very old patients. As reported in previous
studies [12,26], the number of medications was also a pre-
dictor of PIP in older patients. Patients in long-term care
frequently have multiple diseases resulting in complex
medication regimens, which makes assessment of the
risks versus benefits of treatments often difficult. Female
gender was previously reported as a predictor of PIP
[7,12]. Although we observed gender differences in the
prescribed therapeutic classes, female gender was not a
predictor of PIPs in our study.
The results presented here should be viewed in light of
potential limitations. As in previous studies [15], we did
not abstract information on diagnoses from the patients
charts and drug prescriptions were considered as surro-
gates for disease conditions. Thus, the explicit criteria used
in this study apply to general circumstances, but may not
be applicable to specific cases, since they do not consider
clinical information. For example, lipid-lowering drugs
may be potentially inappropriate in patients aged 75 and
Table 3: Most common potentially inappropriate prescriptions (PIPs) among older patients receiving medication in long-term care
Criteria Number of patients Proportion of all patients prescribed a 
medication (%) (N = 2,481)
Potentially inappropriate medication 365 14.7
Long-acting benzodiazepines 138 5.6





Chloral hydrate 22 0.9
Potentially inappropriate duration 585 23.6
Intermediate and short-acting benzodiazepines at 
bedtime for more than one month
567 22.9
Oxazepam at bedtime for more than one month 313 12.6
Potentially inappropriate dosage 239 9.6
Haloperidol > 3 mg daily 129 5.2
Thioridazine > 30 mg daily 53 2.1
Lorazepam > 3 mg daily 34 1.4
Potential drug-drug interaction 842 33.9
Repeat* prescription of antipsychotics 409 16.5
Repeat* prescription of benzodiazepine 369 14.9
Clonazepam and other benzodiazepine 46 1.9
Benzodiazepine and hypnotic or sedative 93 3.8
Repeat* prescription of calcium channel blockers 77 3.1
Repeat* prescription of tricyclic antidepressants 37 1.5
Repeat* prescription of angiotensin converting 
enzyme inhibitors
19 0.8
Repeat* prescription of β-blockers 11 0.4
Repeat* prescription of non-steroidal anti-
inflammatory drugs (except acetylsalicylic acid)
10 0.4
Repeat* prescription of barbiturate 10 0.4
Total potential inappropriate prescriptions** 1,358 54.7
*Repeat prescription indicates that two agents of the same drug class are being prescribed
**Numbers do not add up since one prescription may be linked to more than one PIP (e.g., duration and dosage)Page 6 of 9
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may be of benefit if the patient's life expectancy exceeds
two years [39]. Thus, misidentification of potential cases
of appropriate or inappropriate prescribing may have
occurred, since complex medical conditions can alter the
risk-benefit profile of medications. However, due to the
frail condition of most patients, it is unlikely that such
misidentifications have occurred frequently. Since access
to clinical data is often difficult in the nursing home set-
ting, a list of explicit criteria that does not require that type
of information may be easier to apply on a larger scale.
This study evaluated prescription patterns rather than the
actual consumption of medication. The low prevalence of
as-needed medication (14%) and the long-term care set-
ting, in which medication is administered to patients by a
health caregiver, suggest that this limitation did not have
a significant impact on the results. As-needed prescrip-
tions may have accounted for repeat prescriptions, which
may in turn have led to overestimation of the number of
drug-drug interactions. However, even after excluding as-
needed prescriptions from the analysis, the proportion of
residents with a PIP remains high.
Predictors of PIPs were assessed using a multivariate anal-
ysis. It allowed us to adjust for potential confounding var-
iables. However, we were not able to adjust for facility
variables as those were not available.
This study is the first to describe and qualify prescribing
practices in long-term care facilities in urban Quebec. In
particular, it highlights the extent of potentially inappro-
priate prescribing in elderly long-term care patients,
which are among the frailest of society [4,21]. Inappropri-
ate prescribing is one component of the major health care
problem of suboptimal prescribing that also includes
underuse of effective agents, drug-disease interactions and
prescription errors. Substantial morbidity, mortality and
cost are attributed to suboptimal prescribing [1,2].
Although a decline in the prevalence of PIPs was reported
in community-dwelling older patients in the United States
between 1987 and 1996 [40], the continued use of inap-
propriate medications is a major concern. A growing body
of evidence suggests that clinical pharmacy and multidis-
ciplinary team interventions can modify suboptimal pre-
scribing in older patients. Modern data management
[15,41] and use of the best clinical evidence could help
practitioners improve the management of complex cases
[40,42]. Recent studies in long-term care settings showed
that physician or pharmacist interventions reduce PIPs
[1,12,16,43], while a clinical review program of prescrip-
tions for community-dwelling patients conducted by a
team of physicians, pharmacists and nurses did not seem
to improve prescribing practices [44].
Conclusions
Inappropriate prescribing is highly prevalent in the elderly
long-term care population in metropolitan Quebec. The
use of a explicit criteria list to identify PIPs is a first step
towards identifying most critical issues and implementing
strategies to improve quality of care and patient safety.
Identifying predictors of PIPs may help to target problems
and prioritize interventions that are most needed in the
rapidly expanding older population.
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